JPWO2022211574A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022211574A5 JPWO2022211574A5 JP2023561148A JP2023561148A JPWO2022211574A5 JP WO2022211574 A5 JPWO2022211574 A5 JP WO2022211574A5 JP 2023561148 A JP2023561148 A JP 2023561148A JP 2023561148 A JP2023561148 A JP 2023561148A JP WO2022211574 A5 JPWO2022211574 A5 JP WO2022211574A5
- Authority
- JP
- Japan
- Prior art keywords
- side chain
- halogen
- arylamide
- oxazol
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210042955 | 2021-04-01 | ||
| KR10-2021-0042955 | 2021-04-01 | ||
| KR10-2022-0040453 | 2022-03-31 | ||
| KR1020220040453A KR102463786B1 (ko) | 2021-04-01 | 2022-03-31 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 만성신장질환의 예방 또는 치료용 조성물 |
| PCT/KR2022/004706 WO2022211574A1 (ko) | 2021-04-01 | 2022-04-01 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 만성신장질환의 예방 또는 치료용 조성물 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2024512813A JP2024512813A (ja) | 2024-03-19 |
| JPWO2022211574A5 true JPWO2022211574A5 (https=) | 2024-04-01 |
| JP2024512813A5 JP2024512813A5 (https=) | 2024-04-01 |
| JP7728030B2 JP7728030B2 (ja) | 2025-08-22 |
Family
ID=83456608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561148A Active JP7728030B2 (ja) | 2021-04-01 | 2022-04-01 | 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物を含む慢性腎疾患の予防または治療用組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240216341A1 (https=) |
| EP (1) | EP4317140A4 (https=) |
| JP (1) | JP7728030B2 (https=) |
| AU (2) | AU2022248891A1 (https=) |
| BR (1) | BR112023020026A2 (https=) |
| CA (1) | CA3213910A1 (https=) |
| WO (1) | WO2022211574A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001083427A1 (en) * | 2000-04-28 | 2001-11-08 | Sankyo Company, Limited | PPARη MODULATORS |
| US8318703B2 (en) * | 2001-12-06 | 2012-11-27 | Fibrogen, Inc. | Methods for improving kidney function |
| EP1388341A1 (en) | 2002-08-07 | 2004-02-11 | Aventis Pharma Deutschland GmbH | Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| WO2011084452A1 (en) | 2009-12-16 | 2011-07-14 | Eli Lilly And Company | Therapeutic uses of soluble alpha-klotho |
| KR101372721B1 (ko) | 2010-06-18 | 2014-03-14 | 이화여자대학교 산학협력단 | Ｉｎｔｅｒｌｅｕｋｉｎ―６ 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
| US10647689B2 (en) * | 2015-04-28 | 2020-05-12 | Sanford Burnham Prebys Medical Discovery Institute | Apelin receptor agonists and methods of use thereof |
| KR101770310B1 (ko) | 2015-08-24 | 2017-08-24 | 이화여자대학교 산학협력단 | 2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| KR20250097990A (ko) * | 2016-11-10 | 2025-06-30 | 베링거 인겔하임 인터내셔날 게엠베하 | 약제학적 조성물, 치료 방법 및 이의 용도 |
| EP3611521A1 (en) | 2018-08-16 | 2020-02-19 | General Electric Technology GmbH | Apparatus for monitoring a condition of an electrical power transmisison medium |
| IT201900007446A1 (it) * | 2019-05-29 | 2020-11-29 | Giuseppe Castellano | Composizione comprendente citrato e carnitina in grado di attivare la produzione della proteina klotho |
| KR20200145909A (ko) | 2019-06-20 | 2020-12-31 | 주식회사 레이지소사이어티 | 면도날 자동주문 장치 |
| JP7412546B2 (ja) | 2019-10-02 | 2024-01-12 | 克洛索科学公司 | 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物およびその用途 |
| KR102375097B1 (ko) * | 2021-04-01 | 2022-03-17 | 주식회사 클로소사이언스 | 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물 |
-
2022
- 2022-04-01 JP JP2023561148A patent/JP7728030B2/ja active Active
- 2022-04-01 AU AU2022248891A patent/AU2022248891A1/en not_active Abandoned
- 2022-04-01 CA CA3213910A patent/CA3213910A1/en active Pending
- 2022-04-01 US US18/553,392 patent/US20240216341A1/en active Pending
- 2022-04-01 WO PCT/KR2022/004706 patent/WO2022211574A1/ko not_active Ceased
- 2022-04-01 BR BR112023020026A patent/BR112023020026A2/pt unknown
- 2022-04-01 EP EP22781693.1A patent/EP4317140A4/en active Pending
-
2025
- 2025-04-11 AU AU2025202595A patent/AU2025202595A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2592073B1 (en) | Human protein tyrosine phosphatase inhibitors and their use | |
| JP2004534035A5 (https=) | ||
| JP5225076B2 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
| JP2006077019A5 (https=) | ||
| JP2005533835A5 (https=) | ||
| JP2009520769A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JP2004517049A5 (https=) | ||
| RU2013130879A (ru) | Производные оксазолилметилового эфира в качестве агонистов рецептора alx | |
| JP2005526732A5 (https=) | ||
| JP2018535235A5 (https=) | ||
| JP2006516626A5 (https=) | ||
| JP2009501745A5 (https=) | ||
| JP2007531764A5 (https=) | ||
| JP2019501134A5 (https=) | ||
| JP2021534254A5 (ja) | 心臓弁疾患を治療するための医薬組成物 | |
| JP2013544794A5 (https=) | ||
| JP2007522178A5 (https=) | ||
| JP2013507397A5 (https=) | ||
| JPWO2022211574A5 (https=) | ||
| JP2018535226A5 (https=) | ||
| JP2007517886A5 (https=) | ||
| JPWO2022211420A5 (https=) | ||
| CN101506180B (zh) | 人蛋白酪氨酸磷酸酶抑制剂及使用方法 | |
| JP2004510749A5 (https=) |